NOVOZYMES NORTH AMERICA, INC.

Lobbying client · North Carolina · filed 2025 to 2026

$1,140,000 Reported spend

6 Filings counted

1 Firms hired

7 Bills named

Spend is reported income plus in-house expenses across 6 filings. Everything on this page is grouped by the client's LDA id (188965), not by name.

Firms hired 1

NOVOZYMES NORTH AMERICA, INC. $1,140,000 6 filings

Bills named in these filings 7

HR 2756
National Biotechnology Initiative Act of 2025

5 filings
S 1387
National Biotechnology Initiative Act of 2025

3 filings
HR 7366
Dietary Supplement Regulatory Uniformity Act

2 filings
HR 1346
To amend the Clean Air Act with respect to the ethanol waiver for Reid Vapor Pressure under that Act, and for…

1 filing
HR 4864
Ethanol for America Act of 2025

1 filing
S 2591
Ethanol for America Act of 2025

1 filing
S 593
Nationwide Consumer and Fuel Retailer Choice Act of 2025

1 filing

Reported by year 2 years

2026 $360,000 2 filings
2025 $780,000 4 filings

Issues lobbied 4

The count is how many filings named that issue area. A filing reports one lump figure covering every issue on it, so the money above cannot be split between them.

Agencies and chambers lobbied 6

HOUSE OF REPRESENTATIVES 6
SENATE 6
Agriculture, Dept of (USDA) 2
Environmental Protection Agency (EPA) 1
Executive Office of the President (EOP) 1
Food & Drug Administration (FDA) 1

Recent filings 6 total

Q2

NOVOZYMES NORTH AMERICA, INC.

2nd Quarter (Apr 1 - June 30) 2026 · House · Senate · $140,000 expenses · posted Jul 20, 2026

View → Q1

NOVOZYMES NORTH AMERICA, INC.

1st Quarter (Jan 1 - Mar 31) 2026 · House · Senate · $220,000 expenses · posted Apr 20, 2026

View → Q4

NOVOZYMES NORTH AMERICA, INC.

4th Quarter (Oct 1 - Dec 31) 2025 · House · Senate · $150,000 expenses · posted Jan 20, 2026

View → Q3

NOVOZYMES NORTH AMERICA, INC.

3rd Quarter (July 1 - Sep 30) 2025 · House · Senate · $210,000 expenses · posted Oct 20, 2025

View → Q2

NOVOZYMES NORTH AMERICA, INC.

2nd Quarter (Apr 1 - June 30) 2025 · House · Senate · $270,000 expenses · posted Jul 21, 2025

View → Q1

NOVOZYMES NORTH AMERICA, INC.

1st Quarter (Jan 1 - Mar 31) 2025 · House · Senate · $150,000 expenses · posted Apr 21, 2025

View →

Source: federal Lobbying Disclosure Act filings, synced daily. Money is self-reported by the filer and often rounded. Lobbying is legal, disclosed activity.